Lorati Co., Ltd. has unveiled a groundbreaking natural therapy, Lorati Nano-Emulsion, designed to support full recovery for patients suffering from hemorrhagic and ischemic strokes. This innovative treatment represents a significant departure from conventional methods, offering a non-invasive, at-home solution that patients can administer themselves by consuming between 1,600 to 2,000 cc daily. Recovery timelines vary from 12 to 30 months, depending on the type of stroke and the patient's overall health condition.
The science behind Lorati Nano-Emulsion focuses on three critical aspects of stroke recovery: the complete clearance of blood clots and foam cells, the restoration of elasticity in stiffened blood vessels, and the elimination of inhibitory molecules such as AGEs, ALEs, and excessive heavy metals. By addressing these factors, the therapy activates the body's endogenous stem cells, enabling the regeneration of damaged brain tissue through processes of differentiation, dedifferentiation, and proliferation.
Mr. David Lo, CEO of Lorati, emphasizes that the true potential of stem cell therapy lies in harnessing the body's innate regenerative capabilities, rather than relying on external stem cell transplants. This approach has already demonstrated historic success, with a patient recovering fully from a central pontine hemorrhagic stroke—a severe type of brainstem stroke—after 30 months of nano-emulsion therapy. This achievement, unprecedented in medical history, has garnered attention from experts worldwide, including professors at National Taiwan University.
The implications of Lorati Nano-Emulsion extend beyond individual patient recovery, offering a new paradigm in stroke treatment that could reduce reliance on invasive procedures and pharmaceuticals. With its natural composition and focus on activating the body's own healing mechanisms, this therapy presents a promising alternative for stroke patients globally. For more information, visit https://www.lorati.com.tw.
